EXEL - EXELIXIS, INC.
41.28
-0.410 -0.993%
Share volume: 3,438,511
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$41.69
-0.41
-0.01%
Summary score
84%
Profitability
86%
Dept financing
50%
Liquidity
54%
Performance
99%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
13.95%
Return on assets
4.55%
Return on sales
20.84%
Return on invested capital
66.95%
Total debt ratio
88.32%
Debt ratio change over timeo
0%
Current Ratio
2.74%
Quick Ratio
2.71%
Cash Position Ratio
0.91%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
24.77%
Return on assets
7.4%
Return on sales
40.73%
Return on invested capital
83.23%
Total debt ratio
74.19%
Debt ratio change over timeo
0%
Current Ratio
3.12%
Quick Ratio
3.09%
Cash Position Ratio
1.06%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
34%
Return on assets
13.48%
Return on sales
53.84%
Return on invested capital
271.46%
Total debt ratio
60.85%
Debt ratio change over time
0%
Current Ratio
4.32%
Quick Ratio
4.27%
Cash Position Ratio
1.37%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EXEL | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 13.95% | 6.52% | 16.07% | 8% |
| Return on assets | 4.55% | 3.2% | 7.46% | 5.12% |
| Return on sales | 20.84% | 44.03% | 59.59% | 42.46% |
| Return on invested capital | 66.95% | 9.05% | 13.06% | 8.23% |
| Profitability | 71% | 43% | 80% | 50% |
| Total debt ratio | 88.32% | 60.67% | 65.75% | 46.57% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 17% | 19% | 13% |
| Current Ratio | 3.12% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 3.09% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 1.06% | 0.33% | 1.09% | 0.45% |
| Liquididy | 52% | 58% | 52% | 38% |
| Short-term ratios | EXEL | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 24.77% | 6.57% | 13.54% | 7.21% |
| Return on assets | 7.4% | 3.23% | 6.63% | 5.05% |
| Return on sales | 40.73% | 44.59% | 57.77% | 41.29% |
| Return on invested capital | 83.23% | 9.41% | 12.01% | 7.62% |
| Profitability | 93% | 40% | 65% | 44% |
| Total debt ratio | 74.19% | 60.55% | 63.84% | 45.95% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 20% | 22% | 15% |
| Current Ratio | 3.12% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 3.09% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 1.06% | 0.33% | 1.09% | 0.45% |
| Liquididy | 55% | 58% | 54% | 32% |